NGHIÊN CỨU MÔ HÌNH BỆNH TẬT TẠI KHOA HUYẾT HỌC LÂM SÀNG, BỆNH VIỆN TRUNG ƯƠNG QUÂN ĐỘI 108 NĂM 2025

Abstract

Objective: To describe the disease pattern of inpatients and day-treatment patients at the Clinical Hematology Department, 108 Military Central Hospital, in 2025.

Subjects and methods: A retrospective cross-sectional study using Hospital Information System (HIS) data on 1,359 patients with a confirmed hematological diagnosis treated in the department in 2025: 432 inpatients and 927 day-treatment patients. Each patient was counted once within each treatment setting and classified by principal diagnosis (ICD-10).

Results: In 2025 the department recorded 1,099 inpatient episodes and 5,499 day-treatment visits (83.3% of all treatment episodes). Hematological malignancies accounted for 88.0% of inpatients and 94.4% of day-treatment patients. B-cell non-Hodgkin lymphoma (B-NHL) was the most common diagnosis in both settings (39.6% and 35.2%), followed by multiple myeloma (17.6% and 19.8%). Acute leukemia accounted for 15.5% of inpatients, whereas myeloproliferative neoplasms accounted for 26.2% of day-treatment patients.

Conclusion: Most patients treated in the department in 2025 had hematological malignancies, most commonly B-NHL and multiple myeloma. Day treatment accounted for a large share of the department’s activity in terms of both patients and treatment episodes.